Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
In Vivo ; 36(4): 1753-1760, 2022.
Article in English | MEDLINE | ID: mdl-35738599

ABSTRACT

BACKGROUND/AIM: Dark tea, made by fermentation of tea leaves using microorganisms, is well known for its antiobesity effect; however, studies to identify this effect have not been sufficiently conducted. Herein, the anti-obesity effects of post-fermented dark tea were studied in high-fat diet mouse. MATERIALS AND METHODS: Obesity was induced through a high-fat diet in C57BL/6 mice, and then dark tea extract powder (DTP) was orally administered daily for 12 weeks to evaluate the body and organ weights. Changes in the biochemical markers of obesity were evaluated to study the mechanism of the anti-obesity effects of DTP. RESULTS: When DTP was administered to obesity mice, the weight and food intake reduced, blood aspartate aminotransferase (AST), alanine aminotransferase (ALT), triglyceride (TG), low-density lipoprotein-cholesterol (LDL-C) decreased, whereas high-density lipoprotein cholesterol (HDL-C) increased. Histopathology showed that steatosis and inflammation scores were reduced within the liver and adipocyte sizes were reduced within epididymal adipocyte. In addition, a significant decrease in blood insulin and hepatic TG and a significant increase in blood adiponectin were also confirmed. The results of western blot and qPCR in week 12, showed a significant decrease in the mRNA and protein levels of C/EBPα, and the mRNA levels of PPARγ in the liver. CONCLUSION: Dark tea extracts are thought to have an anti-obesity effect by reducing the levels of the main transcription factors that promote adipocyte differentiation, such as C/EBPα, and PPARγ. Therefore, diet products using dark tea extracts could be developed.


Subject(s)
CCAAT-Enhancer-Binding Protein-alpha , PPAR gamma , Animals , CCAAT-Enhancer-Binding Protein-alpha/genetics , CCAAT-Enhancer-Binding Protein-alpha/metabolism , CCAAT-Enhancer-Binding Protein-alpha/pharmacology , Cholesterol , Diet, High-Fat/adverse effects , Down-Regulation , Liver/pathology , Mice , Mice, Inbred C57BL , Obesity/metabolism , PPAR gamma/genetics , PPAR gamma/metabolism , Plant Extracts/chemistry , Plant Extracts/pharmacology , RNA, Messenger/metabolism , Tea/chemistry , Triglycerides/metabolism , Triglycerides/pharmacology
2.
Biomed Res Int ; 2019: 4252349, 2019.
Article in English | MEDLINE | ID: mdl-30984781

ABSTRACT

BACKGROUND: Local anesthetics are used in various purposes from topical and infiltration anesthesia to peripheral nerve or central neural blockade. Even though local anesthetics are relatively safe, they can have some toxic and adverse effects. Prolonged sensory and motor block is another example of an unwanted complication. The primary objective of this study was to determine whether insulin has a reversal effect on the peripheral (sciatic) nerve block with lidocaine or bupivacaine. METHODS: The surgically exposed sciatic nerves in rats were blocked with lidocaine or bupivacaine, and then 0.1 ml of normal saline or 0.1 ml normal saline containing 0.1 IU a short-acting form of insulin was administrated per body in each group. Before and after sciatic nerve block, as well as until recovery from the nerve block after normal saline or insulin treatment, nerve conduction studies such as monitoring loss and recovery of the waveforms and amplitudes were performed to evaluate the status of motor nerve conduction. RESULTS: Complete recovery time of nerve conduction status in lidocaine + normal saline group was 58 ± 16 min, whereas that in lidocaine + insulin group was 17 ± 3 min and the difference was statistically significant (p < 0.01). Complete recovery time of nerve conduction status in bupivacaine + normal saline group was 116 ± 16 min and that in bupivacaine + insulin group was 36 ± 4 min and the two groups were significantly different (p < 0.01). CONCLUSIONS: Insulin can reverse peripheral nerve block induced by lidocaine or bupivacaine.


Subject(s)
Insulin/administration & dosage , Nerve Block/methods , Sciatic Nerve/drug effects , Sciatic Neuropathy/drug therapy , Anesthesia, Local/methods , Animals , Bupivacaine/administration & dosage , Disease Models, Animal , Drug Combinations , Humans , Lidocaine/administration & dosage , Rats , Sciatic Nerve/pathology , Sciatic Neuropathy/pathology
3.
Biomed Res Int ; 2017: 5205476, 2017.
Article in English | MEDLINE | ID: mdl-29226141

ABSTRACT

The objective of this study was to evaluate the use of immunosuppressive therapy with high-dose cyclosporine, high-dose azathioprine, and a combination of low-dose cyclosporine and azathioprine after tracheal reconstruction by using a trachea-mimetic graft of polycaprolactone (PCL) bellows-type scaffold in a rabbit model. Twenty-four healthy New Zealand white rabbits were used in the study. All underwent circumferential tracheal replacement using tissue-engineered tracheal graft, prepared from PCL bellows scaffold reinforced with silicone ring, collagen hydrogel, and human turbinate mesenchymal stromal cell (hTMSC) sheets. The control group (Group 1) received no medication. The three experimental groups were given daily cyclosporine intramuscular doses of 10 mg/kg (Group 2), azathioprine oral doses of 5 mg/kg (Group 3), and azathioprine oral doses of 2.5 mg/kg plus cyclosporine intramuscular doses of 5 mg/kg (Group 4) for 4 weeks or until death. Group 1 had longer survival times compared to Group 2 or Group 3. Each group except for Group 1 experienced decreases in amount of nutrition and weight loss. In addition, compared with the other groups, Group 2 had significantly increased serum interleukin-2 and interferon-γ levels 7 days after transplantation. The results of this study showed that the administration of cyclosporine and/or azathioprine after tracheal transplantation had no beneficial effects. Furthermore, the administration of cyclosporine had side effects, including extreme weight loss, respiratory distress, and diarrhea. Therefore, cyclosporine and azathioprine avoidance may be recommended for tracheal reconstruction using a native trachea-mimetic graft of PCL bellows-type scaffold in a rabbit model.


Subject(s)
Immunosuppressive Agents/pharmacology , Trachea/surgery , Animals , Azathioprine/pharmacology , Biomimetics/methods , Cells, Cultured , Cyclosporine/pharmacology , Graft Survival/drug effects , Humans , Immunosuppression Therapy/methods , Mesenchymal Stem Cells/drug effects , Rabbits , Tissue Engineering/methods , Tissue Scaffolds
4.
Biomed Res Int ; 2015: 235108, 2015.
Article in English | MEDLINE | ID: mdl-25688353

ABSTRACT

The aim of this study was to evaluate the bone regeneration of hydroxyapatite (HA)/alumina bilayered scaffold with a 3 mm passage-like medullary canal in a beagle tibia model. A porous HA/alumina scaffold was fabricated using a polymeric template-coating technique. HA/alumina scaffold dimensions were 10 mm in outer diameter, 20 mm in length, and with either a 3 mm passage or no passage. A 20 mm segmental defect was induced using an oscillating saw through the diaphysis of the beagle tibia. The defects of six beagles were filled with HA/alumina bilayered scaffolds with a 3 mm passage or without. The segmental defect was fixated using one bone plate and six screws. Bone regeneration within the HA/alumina scaffolds was observed at eight weeks after implantation. The evaluation of bone regeneration within the scaffolds after implantation in a beagle tibia was performed using radiography, computerized tomography (CT), micro-CT, and fluorescence microscopy. New bone successfully formed in the tibia defects treated with 3 mm passage HA/alumina scaffolds compared to without-passage HA/alumina scaffolds. It was concluded that the HA/alumina bilayered scaffold with 3 mm passage-like medullary canal was instrumental in inducing host-scaffold engraftment of the defect as well as distributing the newly formed bone throughout the scaffold at 8 weeks after implantation.


Subject(s)
Aluminum Oxide/pharmacology , Bone Regeneration/drug effects , Durapatite/pharmacology , Tibia/drug effects , Tissue Scaffolds/chemistry , Animals , Dogs , Kaplan-Meier Estimate , Tibia/injuries
5.
Phytother Res ; 27(3): 438-47, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22628265

ABSTRACT

Magnolia bark contains several compounds such as magnolol, honokiol, 4-O-methylhonokiol, obovatol, and other neolignan compounds. These compounds have been reported to have various beneficial effects in various diseases. There is sufficient possibility that ethanol extract of Magnolia officinalis is more effective in amyloidogenesis via synergism of these ingredients. Neuroinflammation has been known to play a critical role in the pathogenesis of Alzheimer's disease (AD). We investigated whether the ethanol extract of M. officinalis (10 mg/ kg in 0.05% ethanol) prevents memory dysfunction and amyloidogenesis in AD mouse model by intraperitoneal lipopolysaccharide (LPS, 250 µg/ kg/day for seven times) injection. We found that ethanol extract of M. officinalis prevented LPS-induced memory deficiency as well as inhibited the LPS-induced elevation of inflammatory proteins, such as inducible nitric oxide synthase and cyclooxygenase 2, and activation of astrocytes and microglia. In particular, administration of M. officinalis ethanol extract inhibited LPS-induced amyloidogenesis, which resulted in the inhibition of amyloid precursor protein, beta-site amyloid-precursor-protein-cleaving enzyme 1 and C99. Thus, this study shows that ethanol extract of M. officinalis prevents LPS-induced memory impairment as well as amyloidogenesis via inhibition of neuroinflammation and suggests that ethanol extract of M. officinalis might be a useful intervention for neuroinflammation-associated diseases such as AD.


Subject(s)
Amyloidosis/drug therapy , Inflammation/drug therapy , Magnolia/chemistry , Memory Disorders/drug therapy , Plant Extracts/pharmacology , Amyloid beta-Protein Precursor/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Astrocytes/drug effects , Brain/drug effects , Brain/pathology , Cyclooxygenase 2/metabolism , Lipopolysaccharides/adverse effects , Male , Memory Disorders/chemically induced , Mice , Mice, Inbred ICR , Microglia/drug effects , Nitric Oxide Synthase Type II/metabolism , Plant Bark/chemistry
6.
J Long Term Eff Med Implants ; 21(2): 159-67, 2011.
Article in English | MEDLINE | ID: mdl-22043974

ABSTRACT

Bone defects resulting from trauma or pathology represent a common and significant clinical problem. In this study, hydroxyapatite (HAp)-alumina bi-layered scaffolds, which have the benefits of both HAp (i.e., osteointegration, osteoconduction) and alumina (i.e., hardness) were used as a bone substitute for the repair of large segmental defects (20 mm) created in a beagle tibia model. Highly porous bi-layered scaffolds with isotropic-pore structures were fabricated using a polymer-template coating technique. The pore sizes obtained using this approach ranged between 230 µm and 470 µm, and porosity was 91.61±1.28%. Using scanning electron microscopy and energy dispersive spectroscopy, it was confirmed that the frame of each bi-layered scaffold consisted of an alumina inner layer and HAp outer layer. The evaluation of bone regeneration within each scaffold after implantation in the beagle tibia was performed using CT, micro-CT, scintigraphy. New bone formation was evident in the large segmental defects treated with HAp/alumina scaffolds. It was concluded from this study that the HAp/alumina bi-layered scaffold is instrumental in inducing host-scaffold engraftment at the distal and proximal ends of the defect as well as distributing the newly formed bone throughout each scaffold 8 weeks post-implantation.


Subject(s)
Aluminum Oxide/pharmacology , Biocompatible Materials/pharmacology , Bone Regeneration , Durapatite/pharmacology , Tibia/injuries , Tibia/physiology , Animals , Dogs , Microscopy, Electron, Scanning , Models, Animal , Pilot Projects , Tibia/ultrastructure , Tissue Scaffolds
7.
Am J Chin Med ; 38(6): 1015-25, 2010.
Article in English | MEDLINE | ID: mdl-21061457

ABSTRACT

The clinical efficacy of electroacupuncture and acupuncture in combination with medication for the treatment of thoracolumbar intervertebral disc herniation was investigated in paraplegic dogs with intact deep pain perception. To evaluate the additional effect of electroacupuncture, dogs treated with conventional medicines alone were compared to dogs treated with electroacupuncture and acupuncture and conventional medicine. Medical records of 80 dogs were reviewed for this investigation and classified into two groups undergoing different treatment methods: (1) treatment with conventional medicine alone (Group C, n = 37) and (2) treatment with conventional medicine combined with electroacupuncture and acupuncture (Group CE, n = 43). Prednisone was the conventional medicine and electroacupuncture was applied at GV07 and GV02-1 at 0.5-2.5 mV, mixed Hz of 2 and 15 Hz for 25-30 min. Acupuncture was performed locally at urinary bladder meridian points near the lesion, and bilaterally distantly at GB30, GB34, and ST36. Treatment efficacy was evaluated by post-operative neurologic function, ambulation, relapse, complication, and urinary function. Ambulation recovery was more prevalent in Group CE than Group C (p = 0.01) and recovery of ambulation and back pain relief time was shorter in Group CE compared to Group C (p = 0.011 and 0.001, respectively). Relapse rate was significantly lower in Group CE (p = 0.031). The results suggest that a combination of electroacupuncture and acupuncture with conventional medicine is more effective than conventional medicine alone in recovering ambulation, relieving back pain, and decreasing relapse. Electroacupuncture and acupuncture is thus a reasonable option for the treatment of intervertebral disc herniation in paraplegic dogs with intact deep pain perception.


Subject(s)
Back Pain/veterinary , Electroacupuncture/veterinary , Glucocorticoids/therapeutic use , Intervertebral Disc Displacement/veterinary , Paraplegia/veterinary , Prednisone/therapeutic use , Walking/physiology , Acupuncture Points , Animals , Back Pain/drug therapy , Back Pain/therapy , Dogs , Electroacupuncture/methods , Glucocorticoids/pharmacology , Intervertebral Disc Displacement/complications , Intervertebral Disc Displacement/therapy , Lumbar Vertebrae , Meridians , Pain Measurement/veterinary , Paraplegia/complications , Prednisone/pharmacology , Recurrence , Thoracic Vertebrae , Treatment Outcome
8.
In Vivo ; 19(4): 801-5, 2005.
Article in English | MEDLINE | ID: mdl-15999553

ABSTRACT

The aim of this study was to assess the inhibitory effect of whole bee venom (BV) on adjuvant-induced arthritis in the rat. Rats were divided into pre-apitherapy, post-apitherapy and control experimental groups. The pre-apitherapy group was subcutaneously stung with a honeybee (Apis mellifera L.) and the control group was subcutaneously injected with 0.1 ml of physiological saline solution one day prior to complete Freund's adjuvant (CFA) injection. The post-apitherapy group was subcutaneously stung with a honeybee on day 14 after CFA injection. When arthritis had developed in the rat, the post-apitherapy group was subcutaneously administered whole BV every other day for a further 14 days. Clinical signs, hematological values and radioglogical features were observed during the entire experimental period. In the pre-apitherapy group, the development of inflammatory edema and polyarthritis was inhibited. Significant differences in lameness score, hind paw edema volume and radiological features were observed between control and pre-apitherapy rats. White blood cell counts indicated that the degree of leucocytosis was significantly different between the pre-apitherapy and control groups (p < 0.01). Inflammatory edema, polyarthritis and bone change into the right hind paw were effectively inhibited in pre-apitherapy rats during the two-week period post-CFA injection. In conclusion, whole BV was found to inhibit arthritic inflammation and bone changes in the rat. This may be an alternative treatment for arthritis in humans.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Arthritis, Experimental/therapy , Bee Venoms/therapeutic use , Animals , Arthritis, Experimental/pathology , Arthritis, Experimental/physiopathology , Disease Models, Animal , Edema/drug therapy , Edema/pathology , Hindlimb/drug effects , Lameness, Animal/drug therapy , Lameness, Animal/physiopathology , Leukocyte Count , Leukocytes/drug effects , Male , Rats , Rats, Sprague-Dawley
9.
In Vivo ; 18(5): 585-91, 2004.
Article in English | MEDLINE | ID: mdl-15523898

ABSTRACT

The aim of this study was to determine whether low-level laser therapy (LLLT) aided the recovery of damaged articular cartilage in joints with artificially induced osteoarthropathy (OA). OA was induced by injecting hydrogen peroxide (H2O2) into the articular spaces of both knees in rabbits, twice a week for 4 weeks. The induction of OA and the effect of LLLT were evaluated by biochemical, radiological and histopathological analysis. Superoxide dismutase (SOD) activity increased about 40% in the OA group, as compared to the controls. Although SOD activity in the OA group was not significantly different from the 2-week groups, it was significantly different from the 4-week control and treatment groups. There was also a significant difference between the 4-week control and treatment groups. Simple radiographs and three-dimensional computed tomographs (3D CT) did not show detectable arthropathy in the OA group, nor any particular changes in the 2-week groups. In contrast, distinct erosions were seen in the distal articular cartilage of the femur, with irregularity of the articular surface, in the 4-week control group, while the erosions were reduced and arthropathy improved slightly in the 4-week treatment group. Grossly, erosions formed on the articular surface in the OA group. In comparison, severe erosions damaged the articular cartilage in the 4-week control group, but not in the 2-week control and treatment groups. Regeneration of articular cartilage was seen in gross observations in the 4-week treatment group. Histopathologically, there was slight irregularity of the articular surface and necrosis in the OA group, and serious cartilage damage, despite slight chondrocyte regeneration, in the 4-week control group. Conversely, the 4-week treatment group showed chondrocyte replacement, with sometimes close to normal articular cartilage on the articular surface. These results suggest that LLLT was effective in the treatment of chemically-induced OA.


Subject(s)
Cartilage, Articular/radiation effects , Low-Level Light Therapy , Osteoarthritis/radiotherapy , Animals , Arthrography , Cartilage, Articular/enzymology , Cartilage, Articular/pathology , Cartilage, Articular/physiology , Disease Models, Animal , Hindlimb , Osteoarthritis/chemically induced , Osteoarthritis/pathology , Rabbits , Regeneration , Stifle/drug effects , Stifle/pathology , Stifle/radiation effects , Superoxide Dismutase/metabolism , Tomography, X-Ray Computed , Treatment Outcome
10.
Am J Chin Med ; 32(4): 521-30, 2004.
Article in English | MEDLINE | ID: mdl-15481642

ABSTRACT

This study was performed to assess the efficacy of alpha-viniferin (Carex humilis Leyss) on adjuvant-induced arthritis in rats. Adjuvant arthritis was induced by a single subcutaneous injection of 0.1 ml complete Freund's adjuvant (CFA) containing 7.5 mg Mycobacterium butyricum suspended in 1 ml sterile paraffin oil into the right hind paw. Forty female Sprague-Dawley rats were injected. Righting reflex was uniformly lost and considered to be the initial point of arthritis development on day 7 after CFA injection. Rats were divided into four groups, and upon development of arthritis, tested groups were orally administered 3 or 10 mg/kg alpha-viniferin or 10 mg/kg ketoprofen every day for 14 days. The control group was orally administered 2 ml of physiological saline solution. Bone mineral density (BMD), radiological changes and edematous volumes were measured for 35 days. Alpha-viniferin suppressed the development of inflammatory edema, and inhibited the bone destruction, noted with a decrease in BMD (p < 0.05). Hind paw edema volume, BMD and radiological changes did not differ significantly in the ketoprofen and alpha-viniferin groups during the entire study period. In conclusion, alpha-viniferin suppressed arthritic inflammation and bony change in rats.


Subject(s)
Arthritis, Experimental/drug therapy , Benzofurans/pharmacology , Animals , Cyclooxygenase Inhibitors/pharmacology , Dose-Response Relationship, Drug , Edema/drug therapy , Female , Femur/drug effects , Ketoprofen/pharmacology , Plant Extracts/pharmacology , Rats , Rats, Sprague-Dawley , Tibia/drug effects
11.
Am J Chin Med ; 31(2): 321-6, 2003.
Article in English | MEDLINE | ID: mdl-12856871

ABSTRACT

This study was designed to examine the therapeutic effect of honeybee (Apis mellifera L.) venom in piglets with bacterial diarrhea Comparison between bee venom- and drug-treated groups was our main concern in the present study. Preweaning piglets were assigned to treated and non-treated control groups. In the treated group, 47 piglets were acupunctured with the worker honeybee once a day for three consecutive days. Two acupoints, GV-1 (Jiao-chao) and ST-25 (Hai-men), were selected for apitherapy. In the control group, 44 piglets were intramuscularly injected with a standard dose of a known antibacterial drug, colistin sulfate (300,000 IU/kg of body weight), and an antidiarrheal drug (berberine, 2 ml/kg) once a day for three consecutive days. At post-treatment, 90.9% of the control piglets and 93.6% of piglets in the treated group recovered from bacterial diarrhea. Bee acupuncture therapy did not show any side effects such as allergy, intoxication, hemorrhage or infection. It is concluded that bee venom therapy was effective in controlling bacterial diarrhea in preweaning piglets.


Subject(s)
Bee Venoms/therapeutic use , Diarrhea/drug therapy , Animals , Diarrhea/microbiology , Diarrhea/pathology , Escherichia coli/drug effects , Microbial Sensitivity Tests , Rectum/pathology , Swine
12.
Am J Chin Med ; 31(1): 149-55, 2003.
Article in English | MEDLINE | ID: mdl-12723765

ABSTRACT

The objective of this study was to determine the clinico-therapeutic effect of worker honeybee venom in sows with oligogalactic syndrome postpartum. Comparison between bee venom- and drug-treated groups was our main concern in the present study. Sows after parturition were assigned to bee venom- and drug-treated groups, respectively. In the bee venom-treated group, 22 sows were bee-acupunctured once a day for 3 consecutive days. Honeybees (Apis mellifera L.) forbee acupuncture were about 15 days old after metamorphosis. Live bees were used to sting the acupoints known as yang-ming (ST-18, 1.5 cm lateral to the base of the last two pairs of teats) and jiao-chao (GV- , at the indentation between the base of tail and the anus). In the drug-treated group, 20 sows were intramuscularly injected with a standard dose of penicillin G (400,000 IU/head) once a day for 3 consecutive days. On post-treatment day 4, 85.0% of the drug-treated group and 90.9% of the bee venom-treated group recovered from oligogalactic syndrome postpartum. The result suggested that apitherapy using worker honeybee is an effective treatment for sows with oligogalactic syndrome postpartum.


Subject(s)
Bee Venoms/therapeutic use , Lactation Disorders/veterinary , Puerperal Disorders/veterinary , Swine Diseases/drug therapy , Animals , Female , Injections, Intramuscular , Lactation Disorders/drug therapy , Penicillin G/therapeutic use , Penicillins/therapeutic use , Puerperal Disorders/drug therapy , Swine
13.
Am J Chin Med ; 30(1): 73-80, 2002.
Article in English | MEDLINE | ID: mdl-12067099

ABSTRACT

This study was performed to assess the clincotherapeutic effect of whole venom of honeybee (Apis mellifera) in adjuvant-induced arthritic rat. Ninety Sprague-Dawley male rats were injected with complete Freund's adjuvant (CFA). Adjuvant arthritis was produced by a single subcutaneous injection of I mg Mycobacterium butyricum suspended in 0.1 ml paraffin oil into the right hind paw. Righting reflex was uniformly lost and considered to be the point of arthritis development on day 14 after CFA injection. The experiments were divided into three groups. When arthritis was developed in the rat, tested groups were administered with prednisolone (10 mg/kg, p.o.) or honeybee venom (one bee, s.c.) every other day for another 14 days. Control group was injected with 0.1 ml of physiological saline solution subcutaneously. Clinical and hematological values with histopathological findings were observed during the drug administration. In treatment groups, the development of inflammatory edema and polyarthritis was suppressed. No significant differences of hind paw edema volume and lameness score between prednisolone and honeybee venom groups were observed during treatment. White blood cell counts of control group showed leucocytosis that was significantly different from the two treatment groups (p < 0.01). Erosions of articular cartilage and inflammatory cell infiltrations into interphalangeal joint were effectively suppressed in treated groups. In conclusion, whole honeybee venom was found to suppress arthritic inflammation in the rat. This may be an alternative treatment of arthritic agony in humans.


Subject(s)
Arthritis, Experimental/drug therapy , Bee Venoms/therapeutic use , Acupuncture , Animals , Anti-Inflammatory Agents/therapeutic use , Arthritis, Experimental/pathology , Blood Cell Count , Edema/pathology , Foot/pathology , Gait/drug effects , Hindlimb/pathology , Leukocyte Count , Male , Prednisolone/therapeutic use , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL